BDBM494936 2-(2,6-dioxopiperidin-3-yl)-5-(4-(2-(1-(4-((1-isopropyl-2-methyl-1H-imidazo[4,5-c]pyridin-6-yl)amino)pyrimidin-2-yl)-4-methoxypiperidin-4-yl)ethyl)piperazin-1-yl)isoindoline-1,3-dione::US10994015, Example 78
SMILES: COC1(CCN2CCN(CC2)c2ccc3C(=O)N(C4CCC(=O)NC4=O)C(=O)c3c2)CCN(CC1)c1nccc(Nc2cc3n(C(C)C)c(C)nc3cn2)n1
InChI Key: InChIKey=FOVZAELMJWNOAX-UHFFFAOYSA-N
Data: 5 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epidermal growth factor receptor (Homo sapiens (Human)) | BDBM494936![]() (2-(2,6-dioxopiperidin-3-yl)-5-(4-(2-(1-(4-((1-isop...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent | Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A... | US Patent US10994015 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor (Homo sapiens (Human)) | BDBM494936![]() (2-(2,6-dioxopiperidin-3-yl)-5-(4-(2-(1-(4-((1-isop...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent | Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A... | US Patent US10994015 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-3 (Homo sapiens (Human)) | BDBM494936![]() (2-(2,6-dioxopiperidin-3-yl)-5-(4-(2-(1-(4-((1-isop...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent | Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A... | US Patent US10994015 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EGFR (L858R, T790M, C797S) (Homo sapiens (Human)) | BDBM494936![]() (2-(2,6-dioxopiperidin-3-yl)-5-(4-(2-(1-(4-((1-isop...) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent | Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A... | US Patent US10994015 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor(L858R, T790M) (Homo sapiens (Human)) | BDBM494936![]() (2-(2,6-dioxopiperidin-3-yl)-5-(4-(2-(1-(4-((1-isop...) | PDB MMDB KEGG B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 250 | n/a | n/a | n/a | n/a | n/a | n/a |
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY US Patent | Assay Description All compounds and PROTACs were serially diluted in three-fold increments using 100% DMSO, followed by an intermediate 10-fold dilution using Buffer A... | US Patent US10994015 (2021) | |||||||||||
More data for this Ligand-Target Pair |